M. Carmen Saiz Guisasola, Md (@msaizguisasola) 's Twitter Profile
M. Carmen Saiz Guisasola, Md

@msaizguisasola

Radiation Oncology Resident.| HM Sanchinarro CIOCC.| Science, kindness and perseverance; The rest will follow.

ID: 1717483353262219264

calendar_today26-10-2023 10:08:59

31 Tweet

36 Followers

144 Following

Matthias Guckenberger (@mat_guc) 's Twitter Profile Photo

DOSIS - RCT in pts with painful vertebral mets Hypothesis: improved LC -> durable pain response First randomized trial with 6 mo pain reduction as prim endpoint N=63 pts randomized to SBRT vs conv. RT Significant benefit of SBRT: 69.4% vs. 41.9% (p=0.02) doi.org/10.1002/cncr.3…

DOSIS - RCT in pts with painful vertebral mets
Hypothesis: improved LC -> durable pain response
First randomized trial with 6 mo pain reduction as prim endpoint
N=63 pts randomized to SBRT vs conv. RT
Significant benefit of SBRT: 69.4% vs. 41.9% (p=0.02)
doi.org/10.1002/cncr.3…
Nat Lester-Coll, MD (@drlestercoll) 's Twitter Profile Photo

#ESTRO24 Important negative trial Sequential chemo-SABR did not improve cancer outcomes, but did increase toxicity vs SABR alone in HNSCC

#ESTRO24 Important negative trial 

Sequential chemo-SABR did not improve cancer outcomes, but did increase toxicity vs SABR alone in HNSCC
SEOR.es (@seor_esp) 's Twitter Profile Photo

Comienza la #GALASEOR24 Acercando la innovación al paciente con un emotivo recuerdo hacia el Dr. Pérez Regadera, fallecido recientemente

Comienza la #GALASEOR24 Acercando la innovación al paciente con un emotivo recuerdo hacia el Dr. Pérez Regadera, fallecido recientemente
ESTRO (@estro_rt) 's Twitter Profile Photo

🌟We're thrilled to announce that Barbara Jereczek-Fossa has been elected as the ESTRO President-elect! With extensive experience within ESTRO, Barbara is a respected professional who will undoubtedly excel in her new role, starting in 2026. Congratulations, Barbara!👏

🌟We're thrilled to announce that Barbara Jereczek-Fossa has been elected as the ESTRO President-elect! With extensive experience within ESTRO, Barbara is a respected professional who will undoubtedly excel in her new role, starting in 2026. Congratulations, Barbara!👏
SEOR.es (@seor_esp) 's Twitter Profile Photo

El 6 de junio se celebra en Madrid la Jornada de Formación: Tumores Gastroesofágicos y Cáncer de Recto Info en seor.es/jornadas/jorna…

El 6 de junio se celebra en Madrid la Jornada de Formación: Tumores Gastroesofágicos y Cáncer de Recto
Info en seor.es/jornadas/jorna…
Radiation Medicine Program (@radmedpm) 's Twitter Profile Photo

Congratulations to #RMPatPM's Dr. Jillian Tsai C. Jillian Tsai, MD, PhD, who won the Princess Margaret Cancer Centre Research Till & McCulloch Paper of the Year - Clinical Award, for her Consolidative Use of Radiotherapy to Block (CURB): #Oligoprogression study published in The Lancet! DOI: doi.org/10.1016/s0140-…

Congratulations to #RMPatPM's Dr. Jillian Tsai <a href="/CJTsaiMDPhD/">C. Jillian Tsai, MD, PhD</a>, who won the <a href="/PMResearch_UHN/">Princess Margaret Cancer Centre Research</a> Till &amp; McCulloch Paper of the Year - Clinical Award, for her Consolidative Use of Radiotherapy to Block (CURB): #Oligoprogression study published in The Lancet! 

DOI: doi.org/10.1016/s0140-…
C. Jillian Tsai, MD, PhD (@cjtsaimdphd) 's Twitter Profile Photo

🚨Now live #ASCO24 Evolving Approaches in HNSCC: State-of-the-Art Updates, chaired by Sana Karam, MD, PhD. 👋💡Sana Karam, MD, PhD provides an outstanding summary of the interplay between IO and RT. "Less is More." RT and IO isn't a one-size-fits-all strategy strategy; rather, we need thoughtful

🚨Now live #ASCO24 Evolving Approaches in HNSCC: State-of-the-Art Updates, chaired by <a href="/KaramLab/">Sana Karam, MD, PhD</a>.

👋💡<a href="/KaramLab/">Sana Karam, MD, PhD</a> provides an outstanding summary of the interplay between IO and RT. "Less is More." RT and IO isn't a one-size-fits-all strategy strategy; rather, we need thoughtful
C. Jillian Tsai, MD, PhD (@cjtsaimdphd) 's Twitter Profile Photo

🚨📢Happening now - HN oral abstracts #ASCO24‼️ PRACTICE CHANGING trial of hypoxia directed major radiation de-escalation as definitive treatment for HPV+OPC by Nancy Lee Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center, showing that 30Gy+Chemo is sufficient for cure, with > 500 pts treated so far.

🚨📢Happening now - HN oral abstracts #ASCO24‼️

PRACTICE CHANGING trial of hypoxia directed major radiation de-escalation as definitive treatment for HPV+OPC by <a href="/imrtlee/">Nancy Lee</a> <a href="/MSK_RadOnc/">Memorial Sloan Kettering Radiation Oncology</a> <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a>, showing that 30Gy+Chemo is sufficient for cure, with &gt; 500 pts treated so far.
Angel Montero Luis (@monthy_a) 's Twitter Profile Photo

Comienza la Jornada de Formación Avanzada para Residentes de Oncología Radioterápica SEOR.es SeorResidentes El futuro ya es suyo, y el presente comienza a serlo #radonc

Comienza la Jornada de Formación Avanzada para Residentes de Oncología Radioterápica <a href="/SEOR_ESP/">SEOR.es</a> <a href="/SeorResidentes/">SeorResidentes</a> 
El futuro ya es suyo, y el presente comienza a serlo #radonc
RadioterapiaHM (@radioterapiahm) 's Twitter Profile Photo

Research lead by Dr. M. López demonstrates that SBRT is useful a for the treatment of small pancreatic neuroendocrine tumors #radonc link.springer.com/article/10.100…

Luis Moreno Sánchez (@radioncoluis) 's Twitter Profile Photo

Ultrahypofractionated Radiation Therapy for Prostate Cancer Including Seminal Vesicles in the Target Volume - A treatment-planning Study Based on the Hypo-RT-PC Fractionation Schedule. pubmed.ncbi.nlm.nih.gov/38883997/

Ultrahypofractionated Radiation Therapy for Prostate Cancer Including Seminal Vesicles in the Target Volume - A treatment-planning Study Based on the Hypo-RT-PC Fractionation Schedule.
pubmed.ncbi.nlm.nih.gov/38883997/